Predicting Positive Radial Margin on Restaging MRI of Patients with Low Rectal Cancer: Can We Do Better?

被引:1
|
作者
Patra, Anurima [1 ]
Lakhani, Aisha [1 ]
Augustine, Antony [1 ]
Mohapatra, Priyanka [1 ]
Eapen, Anu [1 ]
Singh, Ashish [2 ]
Masih, Dipti [3 ]
Ram, Thomas S. [4 ]
Jesudason, Mark R. [5 ]
Mittal, Rohin [5 ]
Chandramohan, Anuradha [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Radiol, Vellore 632004, India
[2] Christian Med Coll & Hosp, Dept Med Oncol, Vellore, India
[3] Christian Med Coll & Hosp, Dept Pathol, Vellore, India
[4] Christian Med Coll & Hosp, Dept Radiat Oncol, Vellore, India
[5] Christian Med Coll & Hosp, Dept Colorectal Surg, Vellore, India
来源
关键词
restaging MRI. low rectal cancer. margins. CRM. DWI; CIRCUMFERENTIAL RESECTION MARGIN; MESORECTAL FASCIA INVASION; NEOADJUVANT CHEMORADIOTHERAPY; RISK-FACTORS; ACCURACY; EXCISION; CHEMOTHERAPY; TUMORS;
D O I
10.1055/s-0043-1774300
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective The aim of this study was to characterize the tissue involving the margin and study if this information will affect margin prediction on restaging magnetic resonance imaging (MRI) in low rectal adenocarcinoma (LRC) patients treated with neoadjuvant long-course chemoradiotherapy (LCCRT). Methods In this retrospective study of nonmetastatic LRC (distal margin <5 cmfrom the anal verge) treated with LCCRT followed by surgery, a radiologist blinded to outcome reread the restagingMRI anddocumented if the radialmarginwas involvedby tumor, fibrosis, ormucin reaction using T2 high-resolution (HR) and diffusion- weighted imaging (DWI). The diagnostic performance of tumor-involving margin on restaging MRI was assessed using surgical histopathology as a reference. Interobserver agreement between three independent radiologists was assessed in a subset. Results We included 133 patients ( 80males and 53 females) with a mean ( range) age of 44.7 (21-86) years and 82% of them had well or moderately differentiated adenocarcinoma. Baseline MRI showed T3 (n = 58) or T4 (n = 60) disease in 89% of the patients. The pathological margin was positive in 21% (n =28) cases. In restaging MRI, the circumferential resection margin (CRM) <= 1mm in 75.1% (n =100) cases and MRI predicted tumor, fibrosis, and mucin reaction at the margin in 60, 34, and 6%, respectively, and histopathology showed tumor cells in 33, 14.7, and 16.6% of them, respectively. LRC with tumor-involving margin and bad response (MR tumor regression grade [mr-TRG] 3-5) on restaging MRI had fourfold increased risk of positive pathological circumferential resection margin (pCRM). There was moderate and fair inter-reader agreement for the tissue type involving the CRM (kappa= 0.471) and mr-TRG ( kappa= 0.266), p< 0.05. The use of both distance criteria and tumor-involving margins improved the diagnostic accuracy for margin prediction from 39 to 66% on restaging MRI.Conclusions Margin prediction on restaging MRI can be improved by characterizing the tissue type involving the margin in low rectal cancer patients. The inter- reader agreement was moderate for determining the tissue type.
引用
收藏
页码:85 / 94
页数:10
相关论文
共 50 条
  • [21] Prevention of Anal Cancer - Can We Do Better?
    Palefsky, Joel
    Berry, Michael
    DISEASES OF THE COLON & RECTUM, 2015, 58 (05) : E76 - E76
  • [22] Disparities in Gastric Cancer: Can we do better?
    Magge, Deepa
    Tan, Marcus
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 2936 - 2938
  • [23] Venous thromboembolism prophylaxis for ambulatory cancer patients, can we do better?
    Hikmat Abdel-Razeq
    Asem Mansour
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 399 - 405
  • [24] GENETIC TESTING REFERRALS FOR ENDOMETRIAL CANCER PATIENTS: CAN WE DO BETTER?
    Shah, M.
    Kupperman, D.
    Stroever, S.
    Riddle, L.
    Kliss, A.
    Chuang, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A89 - A90
  • [25] Progress of MRI in predicting the circumferential resection margin of rectal cancer: A narrative review
    Ma, Yanqing
    Ma, Dongnan
    Xu, Xiren
    Li, Jie
    Guan, Zheng
    ASIAN JOURNAL OF SURGERY, 2024, 47 (05) : 2122 - 2131
  • [26] Thromboprophylaxis in hospitalized patients: can we do it better?
    Yglesias, Marchena P.
    Pesantes, E.
    Santos, Rey R.
    Lorente, Burillo J.
    Castro, F.
    Crusat, Ribo F.
    Redrado, Martret X.
    Gari, Paytubi C.
    Mas, Perez J.
    Domenech, A.
    Gomez de Tejada, Biosca M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1033 - 1033
  • [27] Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Bashir, Mustafa R.
    RADIOLOGY, 2020, 297 (03) : 595 - 596
  • [28] Progress in breast cancer-can we do better?
    Dent, S. F.
    CURRENT ONCOLOGY, 2018, 25 : S7 - S8
  • [29] Adjuvant Therapy of Breast Cancer: Can We Do Better?
    Thomssen, Christoph
    Janni, Wolfgang
    BREAST CARE, 2009, 4 (05) : 292 - 293
  • [30] Can we do better than 'incidental' gallbladder cancer?
    Shukla, Parul J.
    Barreto, George
    Neve, Rakesh
    Mohandas, K. M.
    Shrikhande, Shailesh V.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2184 - 2185